We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Highlights Commitment to Expanded Access to Trials
Gottlieb Highlights Commitment to Expanded Access to Trials
Commissioner Scott Gottlieb unveiled a redesigned FDA website on expanded access to clinical trials on Nov. 8 and said the agency is “deeply committed” to helping critically ill patients with no other treatment options to join trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor